<p>Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Heather McArthur from UT Southwestern Medical Center in Dallas, Texas, summarize the evolution of biomarker-driven treatment approaches for triple-negative breast cancer.</p>

Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Heather McArthur from UT Southwestern Medical Center in Dallas, Texas, summarize the evolution of biomarker-driven treatment approaches for triple-negative breast cancer.

What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

Share What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

Sign up to save your podcasts

What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

More shows like Breast Cancer Update

JAMA Editors' Summary

NEJM This Week

JAMA Clinical Reviews

Lung Cancer Update

Hematologic Oncology Update

Prostate Cancer Update

Gastrointestinal Cancer Update

Gynecologic Oncology Update

Dermatologic Oncology Update

Research To Practice | Oncology Videos

ASCO Daily News

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

The ONS Podcast

The Clinical Problem Solvers

Oncology Today with Dr Neil Love

Two Onc Docs

Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing